Dr. Samuel Welling Beckstead, DO

Dr. Beckstead practices at Premier Eye Care of Eastern Idaho in Idaho Falls, Idaho.

Dr. Beckstead's NPI, 1487041380, was assigned on April 20, 2015. Dr. Beckstead graduated from Arizona College of Osteopathic Medicine - Glendale in 2015. Dr. Beckstead holds Idaho license O-1389.

Dr. Beckstead's primary practice is Premier Eye Care of Eastern Idaho, at 2100 Providence Way, Idaho Falls, ID 83404 in Bonneville County. The practice phone is (208) 529-6600.

Dr. Beckstead's primary practice is Premier Eye Care of Eastern Idaho in Idaho Falls, Idaho. Dr. Beckstead is also affiliated with Mountain View Hospital. Dmand AI also links Dr. Beckstead to 3 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Beckstead practices, 5 sites in all. Vendor and product names are available with a free account.

Ophthalmic plastic and reconstructive surgery is Dr. Beckstead's primary specialty in the NPI Registry, under taxonomy code 207WX0200X. Dr. Beckstead is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Beckstead's licenses on file in 2 states: Idaho and Pennsylvania.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, conjunctivitis, dry eye, eyelid inflammation, glaucoma and hereditary corneal conditions among the conditions Dr. Beckstead treats.

CMS data shows 2,089 Medicare services from Dr. Beckstead across 25 procedure codes in 2024, for 599 Medicare patients. Medicare paid $182,082 for them.

CMS counts 599 Medicare patients who saw Dr. Beckstead in 2024. The largest group is 65 to 74, with 285 patients. 68% of them have high blood pressure, and 64% have high cholesterol. 5% are also on Medicaid. Their average risk score is 0.98, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Beckstead's median patient age at 73, with 57% women.

In 2024, Dr. Beckstead wrote 1,526 Medicare Part D claims for 534 patients. 75% of them were for generic drugs. CMS names the drug for 1,440 of them, across 12 drugs with 11 or more claims each, at $30,853 in total drug cost. In 2023, CMS named 1,193 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Beckstead for performance year 2024, reported as part of a group. Dr. Beckstead accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 125 procedures of cataract surgery by Dr. Beckstead, more than 77% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Beckstead in 2021. Dr. Beckstead's most frequent co-authors are Mona L. Camacci, MD, Anne Marie Poulsen, MD and Christopher L. Weller, MD.

CMS Open Payments shows 38 general payments to Dr. Beckstead from 13 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 53% of the total. Valeant Pharmaceuticals International paid the most, $1,923.

Dr. Beckstead graduated from Arizona College of Osteopathic Medicine - Glendale in 2015.

Dr. Beckstead is in network with 19 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.